Skip to main content
. 2019 May 28;10:1129. doi: 10.3389/fimmu.2019.01129

Table 3.

Animal studies demonstrating that in utero exposure to maternal brain-reactive antibodies can permanently alter the brain, leading to behavioral and cognitive deficits.

Target Animal model Characteristics References
Cerebellar Purkinje cells and brainstem neurons Passive transfer: daily maternal serum injections into pregnant mice from E10 to E17 Decreased exploration Altered motor coordination Cerebellar metabolite abnormalities. (79)
Unknown Passive transfer: IV injections of pooled maternal IgG to pregnant rhesus macaque on gestation days 27, 41 and 55 Hyperactivity Increased stereotypies (92)
LDH/STIP1/CRMP1 (antigens of molecular weights 37 and 73 kDa) Passive transfer: single IV injection of purified maternal IgG into pregnant mice on E12 Delayed pre-weaning motor and sensory development. Increased number of USVs on P8 Males had a longer total USV duration on P8 Increased anxiety-like behaviors in males Slightly shorter social interaction in males (93)
Passive transfer: IV maternal IgG injection into rhesus macaque throughout pregnancy Aberrant social behaviors Enlarged brain volume due to increases in white matter in male offspring. (94)
Single intraventricular maternal IgG injection into E14 mouse embryos Increased repetitive behaviors measured as digging in the marble test and grooming Impaired social interactions (95)
Single intraventricular maternal IgG injection into E14 or E16 mouse embryos Greater number of proliferating stem cells in the SVZ of the neocortex and ganglionic eminence Increased adult brain size and weight Increased adult cortical neuron some volume (96)
Single intraventricular maternal IgG injection into E14 mouse embryos Decreased basal dendritic arborization in layer V pyramidal neurons of the frontal cortex Reduced the dendritic spine number and density in several brain regions (97)
Endogenous production: female mice were immunized prior to pregnancy with antigenic peptides recognized by anti- LDH/STIP1/CRMP1 antibodies. Impaired social interactions Impaired social communication measured by USVs neonatally and as adults. Increased repetitive behaviors measured as grooming (98)
Unknown Passive transfer: daily IP injections of pooled maternal IgG to pregnant mice from E13 to E18. Hyperactivity Increased anxiety Impaired social interactions Increased IL-12 levels on E16 and microglia activation on E18 fetal brains. (99)
Passive transfer: daily IP injections of pooled maternal IgG to pregnant mice from E13 to E18. Greater cell proliferation in the SVZ and SGZ post-natally. Decreased cortical cell survival post-natally. (100)
Caspr2 Passive transfer: single IV injection of anti-Caspr2 IgG to pregnant mice on E13.5 Male fetuses:
1. Thinner cortical plate
2. Fewer proliferating cells in the VZ
3. Reduced number of neurons in the entorhinal cortex
Adult males:
1. Decreased number of GABAergic neurons in the hippocampus
2. Decreased dendritic arborization and spine density in CA1 pyramidal neurons
3. Increased stereotypic behaviors: increased digging measured as digging in the marble test
4. Impaired flexible learning
5. Impaired social interactions
(91)
DNA and NMDAR Endogenous production: female mice were immunized prior to pregnancy with a peptide mimetope of DNA. Passive transfer: single IV injection of NMDAR reactive IgG on E14 to pregnant mice Fetuses:
1. Increased cortical cell death and proliferation
2. Thinner cortical plate •
Adults:
1. Decreased cortical neuron size
2. Decreased cortical volume
3. Cognitive impairments in males
(101)
Endogenous production: female mice were immunized prior to pregnancy with a peptide mimetope of DNA. Increased female fetal death rate (102)

E, Embryonic day; IV, intravenous; LDH, lactate dehydrogenase; STIP1, stress-induced phosphoprotein 1; CRMP, collapsing response mediator protein 1; SVZ, subventricular zone; USVs, ultrasonic vocalizations; P, ponstnatal day; IP, intraperitoneal; SGZ, subgranular zone; Caspr2, Contactin-associated protein-like 2; VZ, ventricular zone; NMDAR, N-Methyl-D-aspartate receptor.